Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma.

de Waal AC, van Harten-Gerritsen AS, Aben KK, Kiemeney LA, van Rossum MM, Blokx WA.

Br J Dermatol. 2014 Apr;170(4):874-7. doi: 10.1111/bjd.12898.

PMID:
24593233
2.

How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.

Caldarella A, Fancelli L, Manneschi G, Chiarugi A, Nardini P, Crocetti E.

J Cancer Res Clin Oncol. 2016 Jan;142(1):73-6. doi: 10.1007/s00432-015-2007-1.

PMID:
26113451
3.

Implementation of the 7th Edition AJCC Staging System: Effects on Staging and Survival for pT1 Melanoma. A Dutch Population Based Study.

Oude Ophuis CM, Louwman MW, Grünhagen DJ, Verhoef C, van Akkooi AC.

Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30607. [Epub ahead of print]

PMID:
28109000
4.

[Mitosis in early invasive malignant melanoma. How reliable is histogenetic classification at stage pT1?].

Bösmüller H, Haitchi-Petnehazy S, Hintringer T, Mentzel T.

Pathologe. 2012 Mar;33(2):113-7. doi: 10.1007/s00292-011-1465-8. German.

PMID:
21845361
5.

Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients.

Ponti G, Pollio A, Cesinaro AM, Pellacani G, Magnoni C, Seidenari S.

Cancer Epidemiol. 2012 Jun;36(3):303-5. doi: 10.1016/j.canep.2011.11.003.

PMID:
22153914
6.

Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.

Sekula-Gibbs SA, Shearer MA.

Dermatol Surg. 2011 Aug;37(8):1080-8. doi: 10.1111/j.1524-4725.2011.02015.x. Review.

PMID:
21635622
7.

Sentinel node biopsy improves prognostic stratification in patients with thin (pT1) melanomas and an additional risk factor.

Mitteldorf C, Bertsch HP, Jung K, Thoms KM, Schön MP, Tronnier M, Kretschmer L.

Ann Surg Oncol. 2014 Jul;21(7):2252-8. doi: 10.1245/s10434-014-3641-6.

PMID:
24652352
8.

American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.

Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM 3rd.

Ann Surg Oncol. 2006 Feb;13(2):198-204.

PMID:
16418885
9.

Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.

Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R Jr, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL.

Biomed Res Int. 2013;2013:898719. doi: 10.1155/2013/898719.

10.

Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?

Kirkland EB, Zitelli JA.

Dermatol Surg. 2014 Sep;40(9):937-45. doi: 10.1097/01.DSS.0000452619.94264.ff. Review.

PMID:
25072127
11.

The importance of mitosis as a factor for predicting sentinel lymph node biopsy for thin melanoma.

Oliveira Filho RS, Jorge MC, Oliveira DA, Oliveira RL, Queiroz Mdo C, Nahas FX.

An Bras Dermatol. 2011 Jul-Aug;86(4 Suppl 1):S107-9. English, Portuguese.

12.

Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.

Mori M, Sugiura M, Kono M, Matsumoto T, Sawada M, Yokota K, Yasue S, Shibata S, Sakakibara A, Nakamura S, Tomita Y, Akiyama M.

J Cutan Pathol. 2013 Dec;40(12):1027-34. doi: 10.1111/cup.12222.

PMID:
24111935
13.

Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.

Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR 3rd, Leong SP.

Arch Dermatol. 1998 Aug;134(8):983-7.

PMID:
9722728
14.

A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas.

Cooper C, Wayne JD, Damstetter EM, Martini M, Gordon J, Guitart J, West DP, Nardone B, Rademaker A, Gerami P.

J Am Acad Dermatol. 2013 Nov;69(5):693-9. doi: 10.1016/j.jaad.2013.07.016.

PMID:
23978604
15.
16.

Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.

Litzner BR, Etufugh CN, Stepenaskie S, Hynan LS, Cockerell CJ.

Am J Dermatopathol. 2012 Dec;34(8):827-32. doi: 10.1097/DAD.0b013e3182604d96.

PMID:
22878366
17.

Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma.

Jacobs IA, Chang CK, DasGupta TK, Salti GI.

Ann Surg Oncol. 2003 Jun;10(5):558-61.

PMID:
12794023
18.

Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients.

Nading MA, Balch CM, Sober AJ.

Semin Cutan Med Surg. 2010 Sep;29(3):142-7. doi: 10.1016/j.sder.2010.06.004.

PMID:
21051007
19.

Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.

Eriksson H, Frohm-Nilsson M, Hedblad MA, Hellborg H, Kanter-Lewensohn L, Krawiec K, Lundh Rozell B, Månsson-Brahme E, Hansson J.

Acta Derm Venereol. 2013 Jul 6;93(4):411-6. doi: 10.2340/00015555-1517.

20.

Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.

Doubrovsky A, De Wilt JH, Scolyer RA, McCarthy WH, Thompson JF.

Ann Surg Oncol. 2004 Sep;11(9):829-36.

PMID:
15313732
Items per page

Supplemental Content

Support Center